Walgreens Boots Alliance Inc (NASDAQ:WBA), a top dividend aristocrat, has filed a Form 13D with the SEC, updating the regulatory body on its ownership stake in AmerisourceBergen Corp. (NYSE:ABC), with which it also has a business partnership. The filing reveals that Walgreens owns just under 15% of AmerisourceBergen’s outstanding shares. The two firms signed a ten-year distribution contract back in March of 2013. You can see the details of the latest, rather large filing below.
You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Walgreens Boots Alliance Holdings LLC | 34,157,955 | 14.96% | ||||
| Walgreens Pharmacy Strategies, LLC | 34,157,955 | 14.96% | ||||
| Bond Drug Company of Illinois, LLC | 34,157,955 | 14.96% | ||||
| Walgreen Eastern Co., Inc. | 34,157,955 | 14.96% | ||||
| Walgreen Arizona Drug Co. | 34,157,955 | 14.96% | ||||
| Walgreen Hastings Co. | 34,157,955 | 14.96% | ||||
| Walgreen Co. | 34,157,955 | 14.96% | ||||
| Alliance Boots Luxembourg S. r.l. | 0 | 0 | 0 | 0% | ||
| Alliance Boots Holdings Limited | 0 | 0 | 0 | 0% | ||
| AB Acquisitions UK Holdco | 0 | 0 | 0 | 0% | ||
| Superior Acquisitions Limited | 0 | 0 | 0 | 0% | ||
| Alliance Boots International Limited | 0 | 0 | 0 | 0% | ||
| Alliance Boots Limited | 0 | 0 | 0 | 0% | ||
| AB Acquisitions UK Topco Limited | 0 | 0 | 0 | 0% | ||
| AB Acquisitions Luxco | 0 | 0 | 0 | 0% | ||
| Alliance Boots GmbH | 0 | 0 | 0 | 0% | ||
| Walgreen Swiss International GmbH | 0 | 0 | 0 | 0% | ||
| Superior Holdings Limited | 0 | 0 | 0 | 0% | ||
| Walgreen International S. r.l. | 0 | 0 | 0 | 0% | ||
| Superior Bermuda GP | 0 | 0 | 0 | 0% | ||
| Superior Luxco | 0 | 0 | 0 | 0% | ||
| Walgreens Boots Alliance Scottish LP | 0 | 0 | 0 | 0% | ||
| WBA | 0 | 0 | 0 | 0% | ||
| Superior Luxco | 0 | 0 | 0 | 0% | ||
| Superior Luxco | 0 | 0 | 0 | 0% | ||
| Walgreen Investments Luxembourg SCS | 0 | 0 | 0 | 0% | ||
| Walgreen International Investments LLC | 0 | 0 | 0 | 0% | ||
| WBA Investments, Inc. | 0 | 0 | 0 | 0% | ||
| Walgreen Investments Co | 0 | 0 | 0 | 0% | ||
| Walgreens Boots Alliance, Inc. | 34,157,955 | 14.96% |
Page 1 of 68 SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE
13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
AMERISOURCEBERGEN CORPORATION
(Name of Issuer)
Common
Stock, par value $0.01 per share
(Title of Class of Securities)
03073E105
(CUSIP Number)
Jan Stern Reed
Senior
Vice President, General Counsel and Corporate Secretary
Walgreens Boots Alliance, Inc.
108 Wilmot Road
Deerfield, Illinois 60015
(847) 315-2500
With
a copy to:
Alan L. Dye, Esq.
Hogan Lovells US LLP
555
Thirteenth Street, N.W.
Washington, D.C. 20004
(202) 637-5600 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
January 18, 2016
(Date of Event Which Requires Filing of This Statement)
If the filing person has
previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following
box. ¨
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for
other parties to whom copies are to be sent.
| * | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover page shall not be
deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
